Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
- PMID: 29988424
- PMCID: PMC6024012
- DOI: 10.3389/fimmu.2018.01421
Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System
Abstract
Much research on infectious diseases focuses on clearing the pathogen through the use of antimicrobial drugs, the immune response, or a combination of both. Rapid clearance of pathogens allows for a quick return to a healthy state and increased survival. Pathogen-targeted approaches to combating infection have inherent limitations, including their pathogen-specific nature, the potential for antimicrobial resistance, and poor vaccine efficacy, among others. Another way to survive an infection is to tolerate the alterations to homeostasis that occur during a disease state through a process called host tolerance or resilience, which is independent from pathogen burden. Alterations in homeostasis during infection are numerous and include tissue damage, increased inflammation, metabolic changes, temperature changes, and changes in respiration. Given its importance and sensitivity, the lung is a good system for understanding host tolerance to infectious disease. Pneumonia is the leading cause of death for children under five worldwide. One reason for this is because when the pulmonary system is altered dramatically it greatly impacts the overall health and survival of a patient. Targeting host pathways involved in maintenance of pulmonary host tolerance during infection could provide an alternative therapeutic avenue that may be broadly applicable across a variety of pathologies. In this review, we will summarize recent findings on tolerance to host lung infection. We will focus on the involvement of innate immune responses in tolerance and how an initial viral lung infection may alter tolerance mechanisms in leukocytic, epithelial, and endothelial compartments to a subsequent bacterial infection. By understanding tolerance mechanisms in the lung we can better address treatment options for deadly pulmonary infections.
Keywords: host tolerance; innate immunity and responses; lung endothelium; lung epithelium; lung infections; pneumonia; tissue repair and regeneration.
Figures

Similar articles
-
Coinfection With Influenza A Virus and Klebsiella oxytoca: An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections.Front Immunol. 2018 Oct 29;9:2377. doi: 10.3389/fimmu.2018.02377. eCollection 2018. Front Immunol. 2018. PMID: 30420852 Free PMC article.
-
Innate host responses to enteric bacterial pathogens: a balancing act between resistance and tolerance.Cell Microbiol. 2012 Apr;14(4):475-84. doi: 10.1111/j.1462-5822.2012.01750.x. Epub 2012 Feb 15. Cell Microbiol. 2012. PMID: 22233392 Review.
-
Disease tolerance: a protective mechanism of lung infections.Front Cell Infect Microbiol. 2023 May 3;13:1037850. doi: 10.3389/fcimb.2023.1037850. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37207185 Free PMC article. Review.
-
Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.Front Immunol. 2020 Feb 11;11:105. doi: 10.3389/fimmu.2020.00105. eCollection 2020. Front Immunol. 2020. PMID: 32117259 Free PMC article. Review.
-
Disease Tolerance during Viral-Bacterial Co-Infections.Viruses. 2021 Nov 25;13(12):2362. doi: 10.3390/v13122362. Viruses. 2021. PMID: 34960631 Free PMC article. Review.
Cited by
-
Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation.Front Immunol. 2020 May 19;11:814. doi: 10.3389/fimmu.2020.00814. eCollection 2020. Front Immunol. 2020. PMID: 32508813 Free PMC article. Review.
-
The role of Mycobacterium tuberculosis exosomal miRNAs in host pathogen cross-talk as diagnostic and therapeutic biomarkers.Front Microbiol. 2024 Aug 8;15:1441781. doi: 10.3389/fmicb.2024.1441781. eCollection 2024. Front Microbiol. 2024. PMID: 39176271 Free PMC article. Review.
-
Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.Cell Tissue Bank. 2020 Sep;21(3):405-425. doi: 10.1007/s10561-020-09842-3. Epub 2020 Jun 25. Cell Tissue Bank. 2020. PMID: 32588163 Free PMC article. Review.
-
Talaromyces marneffei activates the AIM2-caspase-1/-4-GSDMD axis to induce pyroptosis in hepatocytes.Virulence. 2022 Dec;13(1):963-979. doi: 10.1080/21505594.2022.2080904. Virulence. 2022. PMID: 35639503 Free PMC article.
-
A Case of Influenza B and Mycoplasma pneumoniae Coinfection in an Adult.Case Rep Infect Dis. 2018 Nov 25;2018:3529358. doi: 10.1155/2018/3529358. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 30595929 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources